Development of my medication plan involving patients and patient representatives as co-designers
Main Article Content
Keywords
Medication Plan, Patient safety, Adherent, A non-electronic tool, Medication Record
Abstract
Background: Patient safety is at risk during the transition of care, and a lack of information about medications at hospital discharge could be a contributing factor. To be adherent, many patients request more information about their medication treatment. Objective: My Medication Plan aims to involve patients and patient representatives as co-designers in developing a tool to meet these information needs. Methods: A framework for the Designing Thinking model involving patients and patient representatives was applied. During the inspiration phase, patients’ needs were explored by observing discharge conversations between patients and hospital physicians, followed by an information conversation between the patient and the first author (MS). Patient representatives were invited to participate in the ideation phase to generate ideas and designs for My Medication Plan. Results: Twelve patients and three patient representatives were included in the inspiration- and ideation phases. Among the patients, the most frequent themes during the discharge conversations were medication and medication changes. Least frequent theme was disease prevention. The patient representatives discussed the importance of My Medication Plan being a non-electronic tool with additional pages to document non-prescription medications and boxes for free text. Furthermore, a glossary over medical terms was added in My Medication Plan for explanation. To ensure patient safety the already existing Shared Medication Record given to patient was combined with My Medication Plan. Conclusion: My Medication Plan was developed as a non-electronic tool consisting of a print of the Shared Medication Record and specific documents sharing important medication-related information. Patients and patients’ representatives becoming co-designers are innovative, as the inclusion of both patients and patients’ representatives is innovative as both groups present different perspectives.
References
Transitions: International Perspectives [Internet]. Cham: Springer International Publishing; 2017 [cited 2023 Dec 22]. p. 71–86.
Available from: https://doi.org/10.1007/978-3-319-62346-7_4
2. Hahn-Goldberg S, Chaput A, Rosenberg-Yunger Z, Lunsky Y, Okrainec K, Guilcher S, et al. Tool development to improve
medication information transfer to patients during transitions of care: A participatory action research and design thinking
methodology approach. Res Soc Adm Pharm RSAP. 2022 Jan;18(1):2170–7.
3. Tarn DM, Heritage J, Paterniti DA, Hays RD, Kravitz RL, Wenger NS. Physician communication when prescribing new medications. Arch Intern Med. 2006 Sep 25;166(17):1855–62.
4. Rognan SE, Kälvemark Sporrong S, Bengtsson K, Lie HB, Andersson Y, Mowé M, et al. Discharge processes and medicines
communication from the patient perspective: A qualitative study at an internal medicines ward in Norway. Health Expect Int J
Public Particip Health Care Health Policy. 2021 Jun;24(3):892–904.
5. Fylan B, Marques I, Ismail H, Breen L, Gardner P, Armitage G, et al. Gaps, traps, bridges and props: a mixed-methods study
of resilience in the medicines management system for patients with heart failure at hospital discharge. BMJ Open. 2019 Feb
19;9(2):e023440.
6. Foulon V, Wuyts J, Desplenter F, Spinewine A, Lacour V, Paulus D, et al. Problems in continuity of medication management upon transition between primary and secondary care: patients’ and professionals’ experiences. Acta Clin Belg. 2019 Aug;74(4):263–271.
7. Skovgaard AK, Fuglsang C, Graae EM, Haugaard IB, Christoffersen LB, Ljungmann R, et al. Sundhedsvæsenet ifølge danskerne [Internet]. 2016 [cited 2022 Jan 23] p. 72. Available from: https://www.tryghed.dk/viden/publikationer/sundhed/
sundhedsvaesenet-ifoelge-danskerne
8. Ziaeian B, Araujo KLB, Van Ness PH, Horwitz LI. Medication reconciliation accuracy and patient understanding of intended medication changes on hospital discharge. J Gen Intern Med. 2012 Nov;27(11):1513–20.
9. Svensberg K, Trapnes E, Nguyen D, Hasan RA, Sund JK, Mathiesen L. Patients’ perceptions of medicines information received at hospital discharge in Norway: a qualitative interview study. Int J Clin Pharm. 2021 Feb;43(1):144–53.
10. Borgsteede SD, Karapinar-Çarkit F, Hoffmann E, Zoer J, van den Bemt PMLA. Information needs about medication according to patients discharged from a general hospital. Patient Educ Couns. 2011 Apr;83(1):22–8.
11. Rognan SE, Kälvemark-Sporrong S, Bengtsson KR, Lie HB, Andersson Y, Mowé M, et al. Empowering the patient? Medication
communication during hospital discharge: a qualitative study at an internal medicines ward in Norway. BMJ Open. 2021 Jun
30;11(6):e044850.
12. World Health Organization. Medication safety in transitions of care [Internet]. Geneva, Switzerland; 2019 [cited 2023 Sep
8] p. 50. Report No.: WHO/UHC/SDS/2019.9. Available from: https://www.who.int/publications-detail-redirect/WHO-UHCSDS-2019.9
13. World Health Organization. Medication Without Harm - Global Patien Safety Challenge on Medication Safety. Geneva,
Switzerland; 2017. 14. Hesselink G, Zegers M, Vernooij-Dassen M, Barach P, Kalkman C, Flink M, et al. Improving patient discharge and reducing hospital readmissions by using Intervention Mapping. BMC Health Serv Res. 2014 Sep 13;14:389.
15. Flink M, Hesselink G, Pijnenborg L, Wollersheim H, Vernooij-Dassen M, Dudzik-Urbaniak E, et al. The key actor: a qualitative study of patient participation in the handover process in Europe. BMJ Qual Saf. 2012 Dec;21 Suppl 1(Suppl_1):i89-96.
16. Al-Rashed SA, Wright DJ, Roebuck N, Sunter W, Chrystyn H. The value of inpatient pharmaceutical counselling to elderly patients prior to discharge. Br J Clin Pharmacol. 2002 Dec;54(6):657–64.
17. Hahn-Goldberg S, Okrainec K, Damba C, Huynh T, Lau D, Maxwell J, et al. Implementing Patient-Oriented Discharge Summaries (PODS): A Multisite Pilot Across Early Adopter Hospitals. Healthc Q Tor Ont. 2016;19(1):42–8.
18. Louis-Simonet M, Kossovsky MP, Sarasin FP, Chopard P, Gabriel V, Perneger TV, et al. Effects of a structured patient-centered discharge interview on patients’ knowledge about their medications. Am J Med. 2004 Oct 15;117(8):563–8.
19. Doyle SK, Rippey JC, Jacques A, Rea AM, Kaiser BN, Miller SM, et al. Effect of personalised, mobile-accessible discharge
instructions for patients leaving the emergency department: A randomised controlled trial. Emerg Med Australas EMA. 2020 Dec;32(6):967–73.
20. Cancino RS, Manasseh C, Kwong L, Mitchell SE, Martin J, Jack BW. Project RED Impacts Patient Experience. J Patient Exp. 2017 Dec;4(4):185–90.
21. Mueller PA, Oppenheimer DM. The pen is mightier than the keyboard: advantages of longhand over laptop note taking. Psychol Sci. 2014 Jun;25(6):1159–68.
22. Sundhedsdatastyrelsen. Baggrund for Fælles Medicinkort. [cited 2023 Feb 21]. Baggrund for Fælles Medicinkort -
Sundhedsdatastyrelsen. Available from: https://sundhedsdatastyrelsen.dk/da/registre-og-services/om-faelles-medicinkort/
baggrund-og-organisering/baggrund-og-vision-fmk
23. Bülow C, Flagstad Bech C, Ullitz Faerch K, Trærup Andersen J, Byg Armandi H, Treldal C. Discrepancies Between the Medication List in Electronic Prescribing Systems and Patients’ Actual Use of Medicines. Sr Care Pharm. 2019 May 1;34(5):317–324.
24. Andersen TS, Gemmer MN, Sejberg HRC, Jørgensen LM, Kallemose T, Andersen O, et al. Medicines Reconciliation in the
Emergency Department: Important Prescribing Discrepancies between the Shared Medication Record and Patients’ Actual
Use of Medication. Pharmaceuticals. 2022 Feb;15(2):142.
25. Bülow C, Noergaard JDSV, Faerch KU, Pontoppidan C, Unkerskov J, Johansson KS, et al. Causes of discrepancies between
medications listed in the national electronic prescribing system and patients’ actual use of medications. Basic Clin Pharmacol
Toxicol. 2021 Sep;129(3):221–31.
26. Hahn-Goldberg S, Okrainec K, Huynh T, Zahr N, Abrams H. Co-creating patient-oriented discharge instructions with patients, caregivers, and healthcare providers. J Hosp Med. 2015 Dec;10(12):804–7.
27. Voorberg WH, Bekkers VJJM, Tummers LG. A Systematic Review of Co-Creation and Co-Production: Embarking on the social
innovation journey. Public Manag Rev. 2015 Oct 21;17(9):1333–57.
28. Brown T, Wyatt J. Design Thinking for Social Innovation. Dev Outreach. 2010 Jul;12(1):29–43.
29. Design Thinking for Social Innovation (SSIR) [Internet]. [cited 2023 Feb 17]. Available from: https://ssir.org/articles/entry/
design_thinking_for_social_innovation
30. Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care J Int Soc Qual Health Care. 2007 Dec;19(6):349–57.
31. Martínez-Mesa J, González-Chica DA, Duquia RP, Bonamigo RR, Bastos JL. Sampling: how to select participants in my research study? An Bras Dermatol. 2016;91(3):326–30.
32. Brinkmann S, Tanggaard L. Kvalitative metoder: en grundbog. 3rd ed. Kbh.: Hans Reitzel; 2015.
33. Instituttet for kultur og Samfund - Aarhus Universitet. Uformelt interview [Internet]. [cited 2023 Mar 2]. Available from:
https://metodeguiden.au.dk/uformelt-interview
34. Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006 Jan 1;3(2):77–101.
35. Striim O. Kreativ problemløsning og praktisk idéudvikling [Internet]. 2. København: Gyldendal; 2002. Available from: https:// go.exlibris.link/m83NTqkN
36. Osborn AF. Applied imagination; principles and procedures of creative thinking. New York: Scribner; 1953. 317 p.
37. Indenrigs- og Sundhedsministeriet. LBK nr 1338 af 01/09/2020, Bekendtgørelse af lov om videnskabsetisk behandling af
sundhedsvidenskabelige forskningsprojekter og sundhedsdatavidenskabelige forskningsprojekter [Internet]. Jan 9, 2020.
Available from: http://www.retsinformation.dk/eli/lta/2020/1338
38. WMA - The World Medical Association-WMA Declaration of Helsinki – Ethical Principles for Medical Research Involving Human Subjects [Internet]. [cited 2023 Jul 13]. Available from: https://www.wma.net/policies-post/wma-declaration-of-helsinkiethical-principles-for-medical-research-involving-human-subjects/
39. Scott-Horton T, Vest K, Kliethermes MA. Using patient preference to customize a patient’s medication list. Consult Pharm J Am Soc Consult Pharm. 2014 Aug;29(8):520–30; quiz 531–5.
40. Asher GN, Corbett AH, Hawke RL. Common Herbal Dietary Supplement–Drug Interactions. Am Fam Physician. 2017 Jul 15;96(2):101–7.
41. Pannucci CJ, Wilkins EG. Identifying and Avoiding Bias in Research. Plast Reconstr Surg. 2010 Aug;126(2):619–25.
42. Goodwin MA, Stange KC, Zyzanski SJ, Crabtree BF, Borawski EA, Flocke SA. The Hawthorne effect in direct observation research with physicians and patients. J Eval Clin Pract. 2017 Dec;23(6):1322–8.
43. Landsberger HA. Hawthorne revisited: a plea for an open city. Ithaca, N.Y.: Cornell University; 1957. 119
44. Noble H, Heale R. Triangulation in research, with examples. Evid Based Nurs. 2019 Jul 1;22(3):67–8.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.